Advertisement
Individuals with blood group O may have a reduced risk for severe acute respiratory syndrome coronavirus 2 infection

Individuals With Blood Group O Have Lower Risk for COVID-19

0
And more COVID-19 patients with blood group A or AB require mechanical ventilation, CRRT
Current angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with a slightly lower mortality risk in patients hospitalized with influenza or pneumonia

Certain HTN Meds May Cut Deaths From Influenza, Pneumonia

0
Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia
For patients undergoing elective cancer surgery

COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes

0
Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways
The number of expected U.S. deaths increased considerably from March through July 2020

U.S. Deaths Up 20 Percent From March Through July 2020

0
The United States has had high COVID-19-associated mortality compared with other countries
Symptoms of COVID-19 are a poor marker for severe acute respiratory syndrome coronavirus 2 infection

Symptoms of COVID-19 Poor Marker for SARS-CoV-2 Infection

0
Only 13.9 percent of individuals with positive test reported specific symptoms on the day of the test
Bedside open tracheotomy seems safe for critically ill patients with COVID-19

Bedside Tracheotomy Feasible for Critically Ill COVID-19 Patients

0
No infection identified among surgeons following procedure; postoperative complications rarely seen
For patients hospitalized with COVID-19

Remdesivir Cuts Time to COVID-19 Recovery

0
However, no significant difference in mortality found between remdesivir and placebo groups
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was diagnosed with COVID-19.

Maker of Antibody Cocktail Trump Took Seeks Emergency Use Authorization

0
Although effectiveness has not yet been seen in humans, drug has shown promise in treating mild cases of COVID-19
Patients using QT-prolonging drugs have an increased risk for cardiac events in association with azithromycin versus amoxicillin

Some Patients Have Increase in Cardiac Events With Azithromycin

0
Risk for cardiac events higher with azithromycin versus amoxicillin in those using QT-prolonging drugs